Elilvili Pharma Private Limited
About Elilvili Pharma Private Limited
Data last updated:
Elilvili Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 09 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2017PTC044318. Its GSTIN is 23AAECE8151F1ZW (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prem Kumar Thomare and Vijay Kumar Thombare.
Its last annual general meeting (AGM) was held on 12 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at New 198/8 Old 767/8 Nanda Nagar, Indore, Madhya Pradesh, India – 452011.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.28 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹7,190 (net margin 1.4%) and EBITDA of ₹42,680 (EBITDA margin 8.1%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Elilvili Pharma Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressNew 198/8 Old 767/8 Nanda Nagar, Indore, Madhya Pradesh, India – 452011
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Elilvili Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elilvili Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elilvili Pharma Private Limited, buy the company report.
Financials of Elilvili Pharma Private Limited
FY 2025 filings availableElilvili Pharma Private Limited reported revenue of ₹5.28 Lakh (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 15% fall in the latest year. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42,680 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,190 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elilvili Pharma Private Limited, buy the company report.
Board of directors of Elilvili Pharma Private Limited
Elilvili Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prem Kumar Thomare | Director | 09 Oct 2017 | 9 Years 0 Months | Current |
| Vijay Kumar Thombare | Director | 09 Oct 2017 | 9 Years 0 Months | Current |
Peer comparison
Elilvili Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shrigaurakhshanath Farmer Producer Company Limited | ₹5.28 Lakh (FY 2024) | 131.0% | Kalamnuri, Maharashtra, India | |||
| Pansare Farmer Producer Company Limited | ₹5.28 Lakh (FY 2025) | -1.0% | Nanded, Maharashtra, India | |||
| Perfect Brews & Flavours Private Limited | ₹5.28 Lakh (FY 2023) | 86.0% | Kolkata, West Bengal, India | |||
| Grace (India) Ltd | ₹5.28 Lakh (FY 2025) | -22.0% | Kolkata, West Bengal, India | |||
| Progrow Agritech Private Limited | ₹5.28 Lakh (FY 2025) | -20.0% | Pithoria, Jharkhand, India | |||
| Elilvili Pharma Private Limitedthis company | ₹5.28 Lakh (FY 2025) | ₹7,190 | 1.4% | -15.0% | Indore, Madhya Pradesh, India | |
| Maheshraj Farmer Producer Company Limited | ₹5.28 Lakh (FY 2024) | Nanded, Maharashtra, India | ||||
| Chityala Mandala Farmers Producer Company Limited | ₹5.28 Lakh (FY 2024) | -1.0% | Nalgonda, Telangana, India | |||
| High Value Securities Private Limited | ₹5.28 Lakh (FY 2025) | -45.0% | Kolkata, West Bengal, India | |||
| Sukrsh Infotech Private Limited | ₹5.28 Lakh (FY 2025) | 1081.0% | Ghaziabad, Uttar Pradesh, India | |||
| G.M.Remedies Private Limited | ₹5.28 Lakh (FY 2025) | -4.0% | Punjab, India |
To see the full peer comparison of Elilvili Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elilvili Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elilvili Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elilvili Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECE8151F1ZW | Madhya Pradesh | Active | 30 Dec 2017 |
To see the full GST registrations and return filing status of Elilvili Pharma Private Limited, buy the company report.
Recent activity
Elilvili Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Prem Kumar Thomare was appointed as Director on 09 Oct 2017.
Frequently asked questions
Elilvili Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 09 October 2017 (9+ years old) and is registered under CIN U74999MP2017PTC044318.
Elilvili Pharma has 2 current directors:
- Prem Kumar Thomare - Director
- Vijay Kumar Thombare - Director
The latest financial statements of Elilvili Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 October 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Elilvili Pharma is 23AAECE8151F1ZW, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Elilvili Pharma is U74999MP2017PTC044318. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elilvili Pharma was incorporated on 09 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Elilvili Pharma by revenue are Shrigaurakhshanath Farmer Producer Company Limited, Pansare Farmer Producer Company Limited, Perfect Brews & Flavours Private Limited, Grace (India) Ltd, Progrow Agritech Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Prem Kumar Thomare was appointed as Director on 09 Oct 2017. Vijay Kumar Thombare was appointed as Director on 09 Oct 2017.
The registered office of Elilvili Pharma is at New 1988 Old 7678 Nanda Nagar, Indore, Madhya Pradesh, India – 452011.
Elilvili Pharma operates in the business services industry, in the other services segment.
The compliance status of Elilvili Pharma is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.